← Back to Search

Behavioral Intervention

eHealth Psychosocial Intervention for Parents of Children with Pediatric Cancer

N/A
Recruiting
Research Sponsored by Nemours Children's Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must be the parent or primary caregiver of a child (ages 0 - 18 years old) diagnosed with cancer
Participants must be able to speak and read English or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 20 weeks
Awards & highlights

Study Summary

This trial is testing an eHealth intervention to help parents and caregivers of children with cancer deal with the psychological risks associated with the disease. The goal is to improve coping abilities and decrease negative psychological effects.

Who is the study for?
This trial is for English or Spanish speaking parents or primary caregivers of children (ages 0-18) diagnosed with cancer. They must have internet access via a computer or mobile device. Parents whose child may not survive beyond six months are excluded.Check my eligibility
What is being tested?
The study tests eSCCIP/eSCCIP-SP, an online psychosocial support program aimed at reducing distress, posttraumatic stress, and anxiety among parents while enhancing coping skills during their child's cancer treatment.See study design
What are the potential side effects?
As this is a psychosocial intervention focused on providing emotional support through digital means, there are no direct physical side effects like those associated with medication. However, participants may experience varying levels of emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am the main caregiver for a child with cancer.
Select...
I can speak and read either English or Spanish.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 20 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 20 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
K-6
Secondary outcome measures
Cognitive Emotion Regulation Questionnaire
Coping Self-Efficacy Scale
Distress Thermometer
+4 more

Trial Design

2Treatment groups
Active Control
Group I: eSCCIP/eSCCIP-SPActive Control1 Intervention
The Electronic Surviving Cancer Competently Intervention Program (eSCCIP) is an innovative eHealth intervention that combines cognitive behavioral and family systems therapy to provide parents and caregivers of children with cancer (PCCC) with evidence-based coping skills and psychosocial support focused on the family unit. eSCCIP has three 30-minute, self-directed, online modules which feature a unique mix of original video content and interactive activities, supplemented by three telehealth follow-up sessions. A stakeholder-informed Spanish-language adaption of eSCCIP (eSCCIP-SP) has been developed and will be offered to Spanish-speaking PCCC. eSCCIP aims to reduce acute distress and symptoms of post-traumatic stress while increasing positive coping self-appraisal and use of cognitive coping skills.
Group II: Coping SpaceActive Control1 Intervention
PCCC randomized to the patient education control condition will be given access to a website with information about psychosocial functioning, coping, and PTSS related to pediatric cancer. This website will be hosted on the same platform as the intervention, available in English and Spanish, and will consist of information modified from CopingSpace.org. CopingSpace.org is an evidence-informed website developed by Ryan's Case for Smiles, a national organization dedicated to supporting families impacted by pediatric cancer and other chronic diseases.

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterOTHER
2,973 Previous Clinical Trials
1,789,040 Total Patients Enrolled
Children's Hospital Los AngelesOTHER
232 Previous Clinical Trials
5,076,174 Total Patients Enrolled
University of VirginiaOTHER
754 Previous Clinical Trials
1,244,723 Total Patients Enrolled

Media Library

eSCCIP/eSCCIP-SP (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05294302 — N/A
Pediatric Cancer Research Study Groups: eSCCIP/eSCCIP-SP, Coping Space
Pediatric Cancer Clinical Trial 2023: eSCCIP/eSCCIP-SP Highlights & Side Effects. Trial Name: NCT05294302 — N/A
eSCCIP/eSCCIP-SP (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05294302 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any more opportunities to participate in this research endeavor?

"Clinicaltrials.gov verifies that this clinical trial, initially posted on January 28th 2023 and last modified in November 22nd 2022, is not actively pursuing participants. Still, there are 54 other trials accepting patients currently."

Answered by AI
~233 spots leftby Jun 2026